BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei Y, Peng L, Li Y, Zhang N, Shang K, Duan L, Zhong J, Chen J. Higher Serum CCN3 Is Associated with Disease Activity and Inflammatory Markers in Rheumatoid Arthritis. J Immunol Res 2020;2020:3891425. [PMID: 32455138 DOI: 10.1155/2020/3891425] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Huo J, Guan G, Cai J, Wu L. Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancer. World J Surg Oncol 2022;20:4. [PMID: 34983559 DOI: 10.1186/s12957-021-02485-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Woo MS, Mun S, Kang H. Meta-Analysis of Effect in Serum Bio-Markers for Early Diagnosis: Rheumatoid Arthritis. Biomed Sci Letters 2021;27:298-309. [DOI: 10.15616/bsl.2021.27.4.298] [Reference Citation Analysis]
3 Peng L, Wei Y, Shao Y, Li Y, Liu N, Duan L. The Emerging Roles of CCN3 Protein in Immune-Related Diseases. Mediators Inflamm 2021;2021:5576059. [PMID: 34393649 DOI: 10.1155/2021/5576059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Rebolledo DL, Acuña MJ, Brandan E. Role of Matricellular CCN Proteins in Skeletal Muscle: Focus on CCN2/CTGF and Its Regulation by Vasoactive Peptides. Int J Mol Sci 2021;22:5234. [PMID: 34063397 DOI: 10.3390/ijms22105234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 MacDonald IJ, Huang CC, Liu SC, Lin YY, Tang CH. Targeting CCN Proteins in Rheumatoid Arthritis and Osteoarthritis. Int J Mol Sci 2021;22:4340. [PMID: 33919365 DOI: 10.3390/ijms22094340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
6 Naughton M, Moffat J, Eleftheriadis G, de la Vega Gallardo N, Young A, Falconer J, Hawkins K, Pearson B, Perbal B, Hogan A, Moynagh P, Loveless S, Robertson NP, Gran B, Kee R, Hughes S, McDonnell G, Howell O, Fitzgerald DC. CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis. J Neuroinflammation 2020;17:349. [PMID: 33222687 DOI: 10.1186/s12974-020-02025-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]